Estrogen and estrogen receptors (ERα and ERβ) regulate a multitude of complicated
physiological and pathological processes. Jan-Ake Gustafsson's group discovered ERβ in …

Long non-coding RNAs (lncRNAs) have emerged as crucial regulators in cancer
progression. We found lncRNA DNM1P35 is elevated in ovarian tumors compared to normal …

Ovarian cancer (OVC) is one of the most aggressive gynecological malignancies worldwide.
Although olaparib treatment has shown favorable outcomes against the treatment of OVC, its …

Aim Ovarian cancer is a gynecological malignancy with a poor prognosis. For platinum‐
sensitive relapsed ovarian cancer, maintenance therapy with poly‐ADP ribose polymerase …

Objective Ovarian cancer remains a leading cause of cancer-related deaths in women. Early
detection improves prognosis, but current diagnostic tools still need improvement. We aimed …

BACKGROUND: Matrine has been reported inhibitory effects on ovarian cancer (OC) cell
progression, development, and apoptosis. However, the molecular targets of matrine against …

Background: About 70% of ovarian cancer (OC) patients relapse after initial chemotherapy,
making it crucial to predict survival before second-line treatment. Our previous work …

Purpose To test the efficacy and feasibility of pelvic bone marrow sparing intensity
modulated radiation therapy (PBMS-IMRT) in reducing bone density loss for patients with …

Cancer metabolism is characterized by significant heterogeneity, presenting challenges for
treatment efficacy and patient outcomes. Understanding this heterogeneity and its regulatory …

Abstract Background Asian Americans have the highest ovarian cancer survival across the
major racial groups although it is unclear whether this survival advantage is observed when …